Loading...
Loading...

The Drug Policy Alliance (DPA) is the nation's leading organization promoting drug policies that are grounded in science, compassion, health and human rights.Our supporters are individuals who believe the war on drugs is doing more harm than good. Together we advance policies that reduce the harms of both drug use and drug prohibition, and seek solutions that promote safety while upholding the sovereignty of individuals over their own minds and bodies. We work to ensure that our nation's drug policies no longer arrest, incarcerate, disenfranchise and otherwise harm millions – particularly young people and people of color who are disproportionately affected by the war on drugs.
The Drug Policy Alliance envisions a just society in which the use and regulation of drugs are grounded in science, compassion, health and human rights, in which people are no longer punished for what they put into their own bodies but only for crimes committed against others, and in which the fears, prejudices and punitive prohibitions of today are no more. Our mission is to advance those policies and attitudes that best reduce the harms of both drug use and drug prohibition, and to promote the sovereignty of individuals over their minds and bodies.

From Drug Policy Alliance: As director of communications strategy, Jag Davies works with communications, program, development and senior management staff to oversee production of all DPA publications and to facilitate best practices in the implementation of the organization's messaging and brand identity. Davies manages a team that includes DPA's research coordinator and communications coordinator, as well as external consultant relationships with writers, designers, and multimedia content producers. Davies also plays a key role in DPA's media work. He is regularly quoted in a wide range of media outlets and his writings have appeared in the New York Times, Washington Post, BBC.com, CNN.com, and dozens of regional and online publications. Davies has more than a decade of professional experience working to establish drug policies grounded in science, compassion, health and human rights. Before joining the organization, he served as director of communications for MAPS, a nonprofit pharmaceutical company conducting clinical trials aimed at developing marijuana and certain psychedelic drugs into federally-approved prescription medicines. Davies also previously served as policy researcher for the American Civil Liberties Union (ACLU) Drug Law Reform Project (now known as the Criminal Law Reform Project), where he coordinated local, state, federal, and international efforts to end punitive drug policies that cause the widespread violation of constitutional and human rights. No transcript available for this episode.

Psychedelics Today

Psychedelics Today

Psychedelics Today